Iomeron (Iomeprol)

Iomeprol contains iodine atoms that strongly absorb X‑ray photons. When injected, it distributes within the vascular and extracellular compartments, raising the radiodensity of blood and tissues. This creates a pronounced contrast between structures on X‑ray‑based imaging, allowing detailed visualization of anatomical features.

The dose of Iomeron is determined by the prescribing physician based on the specific imaging study, patient weight, renal function, and the required level of contrast. Healthcare professionals calculate the appropriate volume to achieve optimal image quality while minimizing exposure.

The safety of Iomeron in pregnancy and lactation has not been fully established. It should be used only if the potential diagnostic benefit outweighs any possible risk to the fetus or infant, and the decision should be made by the treating physician in consultation with the patient.

To order Iomeron, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide. After verification of trade or institutional credentials, the sales team will provide pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Iomeron (Iomeprol) is a low‑osmolar, non‑ionic iodinated contrast medium, offering a favorable safety profile compared with high‑osmolar agents. It provides comparable image enhancement while reducing the incidence of discomfort and adverse reactions. Selection among agents depends on patient factors, imaging requirements, and institutional preferences.

Iomeron should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the solution from moisture, direct sunlight, and extreme temperatures. Do not freeze the product, and inspect the vial for particulate matter before use.

Iomeron is administered by a trained healthcare professional as an intravenous or intra‑arterial injection. The solution is typically delivered through a peripheral or central venous line, or directly into an arterial catheter, depending on the imaging protocol and the area being examined.

The most serious risks include severe allergic reactions such as anaphylaxis, acute kidney injury in susceptible patients, and thyroid dysfunction due to iodine load. Prompt recognition and management of these events are essential, and patients should be monitored closely during and after administration.

Iomeron should be avoided in patients with a known hypersensitivity to iodinated contrast media, severe renal impairment, uncontrolled hyperthyroidism, or those who are severely dehydrated without appropriate fluid replacement. The prescribing clinician must assess each patient’s medical history before use.